Explore rare disease as a systems challenge shaped by governance, data, and care design. See why long horizon, integrated approaches improve outcomes.
Rare Disease as a Systems Challenge: Policy, Data, and Care
Explore rare disease as a systems challenge shaped by governance, data, and care design. See why long horizon, integrated approaches improve outcomes.
How to Interpret “Breakthrough” Treatment Claims in Rare Diseases
Learn how to critically assess “breakthrough” treatment claims in rare disease research. Understand evidence stages, avoid hype cycles, and set realistic expectations based on science.
What Strong and Weak Evidence Mean in Medical Research
Understand strong vs weak evidence in medical research, including evidence hierarchy, bias, and expectation control. A clear guide with relevance to rare diseases and clinical decision-making.
How Researchers Confirm a Link Between a Gene and a Disease
How researchers prove that a gene causes a disease. A clear guide to the scientific methodology, evidence standards, and validation process used in rare disease research.
What a New Gene Discovery Actually Means
Gene discoveries are often misunderstood. Learn what a new gene finding really means for diagnosis, research, and patient care in rare diseases.
FDA's New Breakthrough Pathways for Rare Disease Treatments
A clear overview of the FDA’s new 2025 pathways transforming rare disease drug development, including RDEP, guidance updates, and mechanism based approval.
How Many Rare Diseases Are There? Understanding the Global Numbers
Learn why estimates place rare diseases between 7,000 and 10,000 worldwide, how definitions differ, and how genomics is reshaping our understanding of prevalence.